Dr. Stuart Cook: Expert insights on the TruSight® Cardio Sequencing Kit | Illumina Video

16 March 2015

Dr. Stuart Cook, Professor, Imperial College, London and Duke-NUS, Singapore, developer of the TruSight Cardio Sequencing Kit illumina.com/clinical/reproductive-genetic-health/clinical-labs/inherited-condition-screening/inherited-cardiac-conditions.html
 shares his expert insights on how targeted analysis with this kit can uncover inherited cardiac conditions. He highlights the advantages of targeted gene analysis with the TruSight Cardio Sequencing Kit and touches upon its potential applications and promise in cardiology. Physicians can learn more about the TruSight Cardio Sequencing Kit at: illumina.com/clinical/reproductive-genetic-health/healthcare-professionals/inherited-condition-screening-for-children-and-adults/inherited-cardiac-conditions.html
Read about Dr. Stuart Cook and his work: duke-nus.edu.sg/cvmd/content/stuart-cook
Share this article on    
    
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.